Malignant pleural mesothelioma (MPM) is a highly invasive form of lung cancer that
adversely affects the pleural and other linings of the lungs. MPM is a very aggressive tumor …

Understanding the burden of mesothelioma with the contribution of occupational asbestos
exposure globally provides essential foundations for cancer control, policy decisions and …

Background Malignant pleural mesothelioma (MPM) is a rare but fatal cancer, which is
largely caused by exposure to asbestos. Reliable information about the incidence of MPM …

Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer
deaths in both sexes combined. Recent years have seen major advances in the diagnostic …

Abstract Background Randomised controlled trials (RCTs) with systemic therapies for
patients with pre-treated mesothelioma have reported equivocal efficacy results and …

Background Despite significant advancements in treatments such as surgery, radiotherapy,
and chemotherapy, the survival rate for patients with asbestos-related cancers remains low …

Simple Summary Pleural mesothelioma is a neoplastic disease originating from
mesothelium and is commonly associated with asbestos exposure. Despite the progress …

Background: Malignant pleural mesothelioma (MPM) is a rare, highly aggressive tumor
strongly associated with asbestos exposure and characterized by poor prognosis. Currently …

Objectives Recruiting to randomised trials is often challenging particularly when the
intervention arms are markedly different. The Mesothelioma and Radical Surgery 2 …

Malignant pleural mesothelioma (MPM) is a malignancy closely associated with asbestos
exposure. Although early diagnosis provides a chance of effective treatment and better …